Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 41
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
AIDS Res Ther ; 10: 18, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23842109

RESUMEN

BACKGROUND: HIV/TB coinfection remains a major challenge even after the initiation of HAART. Little is known about Mycobacterium tuberculosis (Mtb) specific immune restoration in relation to immunologic and virologic outcomes after long-term HAART during co-infections with latent and active TB. METHODS: A total of 232 adults, including 59 HIV patients with clinical TB (HIV + TB+), 125 HIV patients without clinical TB (HIV + TB-), 13 HIV negative active TB patients (HIV-TB+), and 10 HIV negative Tuberculin Skin TST positive (HIV-TST+), and 25 HIV-TST- individuals were recruited. HAART was initiated in 113 HIV + patients (28 TB + and 85 TB-), and anti-TB treatment for all TB cases. CD4+ T-cell count, HIV RNA load, and IFN-γ responses to ESAT-6/CFP-10 were measured at baseline, 6 months (M6), 18 months (M18) and 24 months (M24) after HAART initiation. RESULTS: The majority of HIV + TB- (70%, 81%, 84%) as well as HIV + TB + patients (60%, 77%, 80%) had virologic success (HIV RNA < 50 copies/ml) by M6, M18 and M24, respectively. HAART also significantly increased CD4+ T-cell counts at 2 years in HIV + TB + (from 110.3 to 289.9 cells/µl), HIV + TB- patients (197.8 to 332.3 cells/µl), HIV + TST- (199 to 347 cells/µl) and HIV + TST + individuals (195 to 319 cells/µl). Overall, there was no significant difference in the percentage of patients that achieved virologic success and in total CD4+ counts increased between HIV patients with and without TB or LTBI. The Mtb specific IFN-γ response at baseline was significantly lower in HIV + TB + (3.6 pg/ml) compared to HIV-TB + patients (34.4 pg/ml) and HIV + TST + (46.3 pg/ml) individuals; and in HIV-TB + patients compared to HIV-TST + individuals (491.2 pg/ml). By M18 on HAART, the IFN-γ response remained impaired in HIV + TB + patients (18.1 pg/ml) while it normalized in HIV + TST + individuals (from 46.3 to 414.2 pg/ml). CONCLUSIONS: Our data show that clinical and latent TB infections do not influence virologic and immunologic outcomes of ART in HIV patients. Despite this, HAART was unable to restore optimal TB responsiveness as measured by Mtb specific IFN-γ response in HIV/TB patients. Improvement of Mtb-specific immune restoration should be the focus of future therapeutic strategies.

2.
Ethiop Med J ; Suppl 2: 9-20, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-24654505

RESUMEN

BACKGROUND: A 17 year old female patient who presented to a tertiary Hospital in Addis Ababa with bilateral painful leg swelling of two months and shortness of breath, associated with cough and haemoptysis of one week duration was reported to the Ministry of Health and the Addis Ababa Health Bureau. The condition was later detected in 18 individuals from 4 households indicating occurrence of an outbreak of unknown cause in Addis Ababa which lasted during May-July 2008. OBJECTIVE: An outbreak investigation was initiated to identify the cause and prevent further spread, morbidity and mortality. METHODS: Using semi-structured questionnaire, quantitative assessment involving individual cases and affected households was conducted to detect aetiology and risk factors. Unaffected households as well as unaffected members of affected households were also included for comparison purpose. Record review of patients visiting hospitals was also done. Data were collected through house to house visits, and using interview of cases admitted to hospital. Samples of cooking oil were collected for laboratory testing. Data analysis was done using SPSS. RESULTS: A total of 182 patients, 50 (27.5%) males and 132 (72.5%) females, were identified till the outbreak was controlled fully. Age varied from 6-90 years. Death was confirmed in 12 cases, 8 of whom were female. The majority of the patients came from the adjoining Lideta (39.0%) and Kolfe Keranyo (31.9%) subcities. History of illness ranged from less than a week to 12 weeks before presentation. Out of the 106 household members of the 24 affected households identified during the first phase of the investigation, 83 were affected. Most family members who infrequently take meals at home, and children aged 3 years and below were spared. The 21 visited affected households from Kolfe keranyo, Lideta and Bole subcities bought cooking oil produced by a firm in Lideta subcity and all had bought their last supplies in March and April 2008. Samples of cooking food oil taken from this firm and from the affected households were found to have alkaloids of Argemone Mexicana. The number of new cases dropped to zero within 6 weeks after the source was closed. CONCLUSION: The occurrence of bilateral leg swelling in more than one family member of affected households, that bought cooking oil from the same source, sparing the toddlers, and those who infrequently take meals at home, further strengthened by laboratory confirmation of presence of argemone alkaloids in the cooking oil samples taken from the affected households and the common sources led to the diagnosis of the outbreak to be epidemic dropsy.


Asunto(s)
Cardiotónicos/efectos adversos , Brotes de Enfermedades , Edema/epidemiología , Edema/terapia , Contaminación de Alimentos , Aceites de Plantas/efectos adversos , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Benzofenantridinas/efectos adversos , Niño , Análisis por Conglomerados , Edema/diagnóstico , Etiopía/epidemiología , Femenino , Humanos , Isoquinolinas/efectos adversos , Extremidad Inferior , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Factores de Riesgo , Adulto Joven
3.
Ethiop Med J ; Suppl 2: 21-32, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-24654506

RESUMEN

BACKGROUND: Food adulteration including adulteration of edible oils may cause serious health problems. One of the most common edible adulterants is argemone oil. An outbreak of epidemic dropsy occurred in Addis Ababa during May-June, 2008. One hundred and eighty two cases were recorded with twelve confirmed deaths. Dietary history of the cases revealed that vegetable oils were the usual cooking medium. OBJECTIVE: The aim of the study was hence to investigate the causes of this outbreak. METHODS: Contaminant identification was done using standard chemical tests, complemented with TLC. Toxicity study was done using Swiss albino mice feed with contaminated and non contaminated standard diet for 30 days. RESULTS: Laboratory investigation of the edible oils has indicated that 47 of the 280 edible oils analyzed were adulterated with argemone oil. About 81% of the edible oil samples collected from Lideta sub-city were adulterated with argemone oil. Toxicological investigation of the adulterated oils also indicated typical features of argemone alkaloid poisoning in mice. CONCLUSION: Results of both laboratory analysis and toxicological studies confirmed consumption of edible oils adulterated with argemone oil as the cause of epidemic dropsy in Addis Ababa.


Asunto(s)
Cardiotónicos/efectos adversos , Brotes de Enfermedades , Edema/epidemiología , Edema/terapia , Contaminación de Alimentos , Aceites de Plantas/efectos adversos , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Animales , Benzofenantridinas/efectos adversos , Benzofenantridinas/toxicidad , Cardiotónicos/toxicidad , Niño , Encuestas sobre Dietas , Edema/diagnóstico , Etiopía/epidemiología , Femenino , Humanos , Isoquinolinas/efectos adversos , Isoquinolinas/toxicidad , Extremidad Inferior , Masculino , Ratones , Persona de Mediana Edad , Aceites de Plantas/toxicidad , Factores de Riesgo , Pruebas de Toxicidad , Adulto Joven
4.
Ethiop Med J ; 49(3): 179-86, 2011 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-21991751

RESUMEN

BACKGROUND: The search for a correlation between chemokine levels in plasma or serum and protection from HIV infection or progression to AIDS has been attempted by a number of workers. Chemokines are also suggested to play a role in immunity to Leishmania and Leishmania co-infection with HIV. OBJECTIVE: To assess plasma level of alpha chemokine (CXCL12, formerly known as SDF-1alpha) and beta chemokines (CCL3, CCL4 and CCL5, formerly known as MIP-1alpha, MIP-1beta and RANTES, respectively) in HIV Visceral Leishmaniasis (VL) and HIV/VL coinfection. METHODS: Frozen serum samples from a cross sectional study were used. The samples (n = 80) were comprised of healthy controls (n = 20), HIV patients (n = 20); Visceral Leishmaniasis (VL) patients (n = 22), and HIV/VL coinfected patients (n = 18). Chemokine levels of MIP-1alpha, MIP-1beta, RANTES, and SDF-1alpha of the serum samples were determined using ELISA. RESULTS: MIP-1alpha and MIP-1beta expression were significantly elevated in Leishmania infected (p < 0.001) and in HIV/ VL co-infected individuals (p < 0.001) as compared to the control groups, while no significant difference was seen between HIV infected patients p > 0.05, implying that VL alone might modulate the production of these two chemokines in the case of co-infection In RANTES, however, its expression was significantly higher in HIV patients compared to controls (p = 0.002). Further assessment of serum RANTES concentration in HIV patients has shown a tendency of negative association with viral load. Higher amount of the alpha chemokine, SDF-1alpha, was detected in the HIV patients (p = 0.001) than the control group. Also a trend of positive association between SDF-1alpha and CD4 count was observed CONCLUSION: From our data we can speculate that RANTES and SDF-1alpha might be involved in the regulation of HIV; and MIP-1alpha and MIP-1beta in VL. Therefore, enhancing or suppressing the production of these chemokines might help in therapeutic intervention of VL or HIV.


Asunto(s)
Quimiocinas CC/sangre , Infecciones por VIH/inmunología , VIH-1/inmunología , Leishmania donovani/inmunología , Leishmaniasis Visceral/inmunología , Infecciones Oportunistas Relacionadas con el SIDA , Adulto , Pruebas de Aglutinación , Biomarcadores/sangre , Western Blotting , Recuento de Linfocito CD4 , Estudios de Casos y Controles , Quimiocinas CC/metabolismo , Estudios Transversales , Ensayo de Inmunoadsorción Enzimática , Femenino , Infecciones por VIH/metabolismo , Infecciones por VIH/virología , VIH-1/aislamiento & purificación , Humanos , Leishmania donovani/aislamiento & purificación , Leishmaniasis Visceral/metabolismo , Leishmaniasis Visceral/virología , Masculino , Persona de Mediana Edad , ARN Viral/sangre , Carga Viral , Adulto Joven
5.
Ethiop Med J ; 47(3): 205-11, 2009 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19954123

RESUMEN

BACKGROUND: Human Herpes Virus (HHV-8) is related to Kaposi Saracoma, an opportunistic infection occurring with HIV infection. Little is known about the seroepidemiology of Human Herpesvirus 8 (HHV-8) infection among Ethiopian women, even though women are a major HIV risk group in Ethiopia. OBJECTIVES: This study aimed at determining the seroprevalence of HHV-8 infection in HIV-1-infected and uninfected pregnant women in five selected regions of Ethiopia. METHODS: A cross-sectional study was conducted from December 2006 to June 2007 where pregnant women were recruited after age-matching in groups. A total of 400 pregnant women were enrolled, with 200 being HIV-infected and 200 being HIV-uninfected Sera were screened for IgG lytic antibody to HHV-8 using an Indirect Fluorescence Assay (IFA) in Virology Unit of Ethiopian Health and Nutrition Research Institute (EHNR1). RESULTS: Of 400 pregnant women attending antenatal clinic (ANC) testing sites of five regions in Ethiopia, 212 (53.0%) were positive for HHV-8 IgG lytic antibody. There was a high prevalence of HHV-8 infection among HIV-1-infected pregnant women (138, 69.0%) as compared with HIV-1-uninfected pregnant women (74, 37.0%). CONCLUSION: The study shows a high prevalence of HHV-8 infection among HIV-1-infected pregnant women as compared with HIV-1-uninfected pregnant women. Therefore, creating awareness and educating women on safe sexual practice and avoiding deep kissing may be a fundamental ways to limit the roots of transmission. Moreover, initiating strong antiretroviral therapy (ART) for HIV infected women would be best treatment prior to the development of Kaposi's sarcoma (KS).


Asunto(s)
Infecciones por VIH/epidemiología , VIH-1 , Herpesvirus Humano 8 , Complicaciones Infecciosas del Embarazo/epidemiología , Sarcoma de Kaposi/epidemiología , Adolescente , Adulto , Estudios Transversales , Etiopía/epidemiología , Femenino , Humanos , Persona de Mediana Edad , Embarazo , Complicaciones Infecciosas del Embarazo/virología , Sarcoma de Kaposi/prevención & control , Estudios Seroepidemiológicos , Sífilis/epidemiología
6.
Antivir Ther ; 13 Suppl 2: 89-94, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18575196

RESUMEN

BACKGROUND: Expanded access to HIV therapy in the developing world raises serious concerns regarding the potential emergence and transmission of drug-resistant HIV strains. Although HIV drug resistance surveillance is recommended to track transmitted HIV drug resistance among newly infected individuals, the financial constraints in resource-limited countries prohibit such surveillance on a regular basis. The World Health Organization (WHO) recently introduced guidelines to address this issue. METHODS: A survey was conducted in Ethiopia following the WHO guidelines to assess transmitted HIV drug resistance among recently HIV-infected individuals in Addis Ababa. Antiretroviral drug usage started 3 years earlier than commencement of the current expanded access to antiretroviral therapy in Ethiopia. RESULTS: Of 75 eligible samples, 39 (52%) were successfully sequenced and genotyped in the protease and reverse transcriptase region, using both the ViroSeq and TrueGene genotyping systems, and analysed for drug resistance mutations using an algorithm from the Stanford HIV Reverse Transcriptase and Protease Database. The analysis revealed that transmitted HIV drug resistance in Addis Ababa is below the 5% threshold level for all three classes of antiretrovirals. CONCLUSIONS: The current first-line antiretroviral therapy strategy can be used with confidence in Ethiopia at this time; however, Ethiopia should conduct similar periodic surveys that include the capitals of Ethiopia's larger regional states to ensure early detection of any changes in the country's HIV drug resistance trend.


Asunto(s)
Antirretrovirales/uso terapéutico , Farmacorresistencia Viral/genética , Infecciones por VIH/transmisión , VIH/genética , Programas Nacionales de Salud , Atención Prenatal , Sector Público , Adulto , Análisis Mutacional de ADN , Bases de Datos Genéticas , Etiopía/epidemiología , Femenino , Genotipo , VIH/enzimología , Infecciones por VIH/tratamiento farmacológico , Infecciones por VIH/epidemiología , Infecciones por VIH/virología , Proteasa del VIH/genética , Transcriptasa Inversa del VIH/genética , Humanos , Programas Nacionales de Salud/estadística & datos numéricos , Embarazo , Atención Prenatal/estadística & datos numéricos , Evaluación de Programas y Proyectos de Salud , Sector Público/estadística & datos numéricos , Vigilancia de Guardia , Resultado del Tratamiento , Organización Mundial de la Salud
7.
Ethiop Med J ; 45(3): 293-9, 2007 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-18330330

RESUMEN

OBJECTIVE: Evaluation and monitoring of Human Immunodeficiency Virus (HIV) testing reagents at the point of service is helpful to prevent the occurrence of problems related to testing and interpretation. To evaluate the implementation of HIV rapid test kits at the point of services in voluntarily counseling and testing (VCT) and diagnostic centers in Ethiopia. METHODS: The assessment was the third phase of evaluation of HIV rapid test kits in Ethiopia followed from phase-I and phase-II. Known proficiency testing panels, well-structured questionnaire (addressing type of tests, human resource and problems related to tests), onsite supervision and retesting of samples collected from sites were used to evaluate the performances of reagents and laboratories. RESULTS: Forty-four health institutions were included. Thirty-six (90.0%) health institutions had trained human resource on HIV testing. In 27 (61.4%) three types of HIV rapid test kits (Determine, Capillus and Unigold) were available. Serial-algorithm was used in all the laboratories. In 31 (70.4%) of them external quality control specimens were not used. Twenty two (50.0%) of the laboratories reported frequent shortage of reagents. All (100%) were able to identify negative specimens distributed. Positive proficiency panel samples were identified in 37 (94.8%) of the 39 laboratories. There was 98.3% agreement at a screening level between the sites and the central laboratory. Rate of discrepancy between screening and confirmatory assays was found to be 3.0% and 2.1% at the sites and at central laboratory, respectively. CONCLUSION: The test kits showed a good performance at the point of services in the field sites. However, continuous assessment of HIV test kits at the point of service and training of professionals on newly arrived techniques are recommended to have effective testing performance with acceptable sensitive and specific testing algorithm. Effective quality assurance program should be in place to support programs such as VCT, prevention of mother-to-child-transmission and antiretroviral therapy.


Asunto(s)
Serodiagnóstico del SIDA , Atención a la Salud , Anticuerpos Anti-VIH/inmunología , Infecciones por VIH/diagnóstico , VIH-1 , Juego de Reactivos para Diagnóstico , Algoritmos , Etiopía , Infecciones por VIH/epidemiología , Seroprevalencia de VIH , Encuestas de Atención de la Salud , Humanos , Tamizaje Masivo , Encuestas y Cuestionarios , Factores de Tiempo
8.
Lancet Infect Dis ; 17(1): e26-e29, 2017 01.
Artículo en Inglés | MEDLINE | ID: mdl-27773596

RESUMEN

Scaling up access to HIV viral load testing for individuals undergoing antiretroviral therapy in low-resource settings is a global health priority, as emphasised by research showing the benefits of suppressed viral load for the individual and the whole population. Historically, large-scale diagnostic test implementation has been slow and incomplete because of service delivery and other challenges. Building on lessons from the past, in this Personal View we propose a new framework to accelerate viral load scale-up and ensure equitable access to this essential test. The framework includes the following steps: (1) ensuring adequate financial investment in scaling up this test; (2) achieving pricing agreements and consolidating procurement to lower prices of the test; (3) strengthening functional tiered laboratory networks and systems to expand access to reliable, high-quality testing across countries; (4) strengthening national leadership, with prioritisation of laboratory services; and (5) demand creation and uptake of test results by clinicians, nurses, and patients, which will be vital in ensuring viral load tests are appropriately used to improve the quality of care. The use of dried blood spots to stabilise and ship samples from clinics to laboratories, and the use of point-of-care diagnostic tests, will also be important for ensuring access, especially in settings with reduced laboratory capacity. For countries that have just started to scale up viral load testing, lessons can be learnt from countries such as Botswana, Brazil, South Africa, and Thailand, which have already established viral load programmes. This framework might be useful for guiding the implementation of viral load with the aim of achieving the new global HIV 90-90-90 goals by 2020.


Asunto(s)
Fármacos Anti-VIH/uso terapéutico , Terapia Antirretroviral Altamente Activa/métodos , Monitoreo de Drogas , Infecciones por VIH/tratamiento farmacológico , Manejo de Especímenes/métodos , Sangre/virología , Desecación/métodos , Salud Global , Infecciones por VIH/prevención & control , Infecciones por VIH/virología , Política de Salud , Humanos , Ciencia del Laboratorio Clínico/organización & administración , Sistemas de Atención de Punto/organización & administración , Carga Viral
9.
Jpn J Infect Dis ; 59(5): 306-10, 2006 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-17060696

RESUMEN

Intestinal microsporidiosis is most commonly associated with persistent diarrhea in advanced AIDS cases. To determine the prevalence and clinical manifestations of this infection in HIV/AIDS patients, a single fresh stool sample and blood were collected from 243 (214 HIV-positive and 29 HIV-negative) diarrheal patients. The presence of intestinal microsporidiosis in the stool was determined by Uvitex-2B staining and a PCR-based detection method. HIV screening was done by using ELISA, and reactive samples were confirmed by Western blotting. The CD4+ cell count was analyzed using FACScan. Out of 243 diarrheal patients, 39 (16.0%) cases were positive for intestinal microsporidial infection by either of the methods used. Of the 39, only 18 cases positive by microscopy were also positive by PCR. Based on PCR and microscopic analyses the microsporidial parasites were identified as Enterocytozoon bieneusi (30), Ecephalitozoon intestinalis (6), and double infections (3). All microsporidia-positive cases were HIV-positive, and 92.3% had diarrhea for over 4 weeks. The diarrhea was watery in 79.5% of the patients. Weight loss >10% was recorded in 37 (94.9%) cases. The CD4+ cell count was <100 cells/mm(3) in 84.4% of subjects, and 59.4% of the patients had a CD4+ cell count of < or =50 cells/mm(3), with a mean of 22.8 cells/mm(3). This study revealed that intestinal microsporidiosis is a common cause of chronic diarrhea and severe weight loss in advanced AIDS patients in Ethiopia. This condition is attributable mainly to E. bieneusi. Thus, early diagnosis of intestinal microsporidiosis in HIV/AIDS patients would certainly be helpful in the understanding and management of diarrheal illness.


Asunto(s)
Diarrea/microbiología , Diarrea/virología , Infecciones por VIH/microbiología , Microsporidiosis/virología , Adulto , Diarrea/epidemiología , Encephalitozoon/aislamiento & purificación , Enterocytozoon/aislamiento & purificación , Etiopía/epidemiología , Heces/microbiología , Femenino , Infecciones por VIH/epidemiología , VIH-1/aislamiento & purificación , Humanos , Incidencia , Enfermedades Intestinales/epidemiología , Enfermedades Intestinales/metabolismo , Enfermedades Intestinales/virología , Masculino , Microsporidiosis/epidemiología , Microsporidiosis/microbiología , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa/métodos
10.
Tuberculosis (Edinb) ; 96: 131-40, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-26631832

RESUMEN

Identification of Mtb specific induced cytokine/chemokine host biomarkers could assist in developing novel diagnostic, prognostic and therapeutic tools for TB. Levels of IFN-γ, IL-2, IL-17, IL-10, IP-10 and MIP-1α were measured in supernatants of whole blood stimulated with Mtb specific fusion protein ESAT-6/CFP-10 using xMAP technology. The study groups were HIV positive TB patients (HIV(+)TB(+)), HIV negative TB patients (HIV(-)TB(+)), HIV positive tuberculin skin test positive (TST+) (HIV(+)TST(+)), HIV negative TST+ (HIV(-)TST(+)), and HIV(-)TST(-) individuals. Compared to HIV(-)TST(-), latent TB infection led to increased levels of IP-10, IFN-γ and IL-17, while levels of IL-2 and IP-10 were increased with active TB. Levels of IFN-γ, IL-17, MIP-1α, and IL-10 were increased in HIV(-)TST(+) individuals compared to HIV(-)TB(+) patients. HIV coinfection decreased the level of IFN-γ, IL-17, IP-10 and IL-2. After six months (M6) of anti-TB treatment (ATT) in HIV(-)TB(+) patients, IFN-γ, IL-10, and MIP-1α levels normalized. After M6 and M18 of ATT plus HAART in HIV(+)TB(+) patients, levels of MIP-1α and IL-10 normalized, while this was not the case for IFN-γ, IL-2, IL-17, and IP-10 levels. In HIV(+)TST(+) patients on HAART, levels of IFN-γ, IL-17, IL-10 and MIP-1α normalized, while no change in the levels of IL-2 and IP-10 were observed. In conclusion, the simultaneous measurement of IFN-γ, IL-17 and IP-10 may assist in diagnosing LTBI; IL-2 and IP-10 may assist in diagnosing active TB; while IFN-γ, IL-17, MIP-1α, and IL-10 levels could help to discriminate LTBI and active TB. In addition, IL-10 and MIP-1α levels could help to monitor responses to TB treatment and HAART.


Asunto(s)
Fármacos Anti-VIH/uso terapéutico , Antígenos Bacterianos/inmunología , Antituberculosos/uso terapéutico , Quimiocinas/inmunología , Citocinas/inmunología , Infecciones por VIH/tratamiento farmacológico , Tuberculosis Latente/tratamiento farmacológico , Mycobacterium tuberculosis/inmunología , Adolescente , Adulto , Anciano , Antígenos Bacterianos/sangre , Terapia Antirretroviral Altamente Activa , Quimiocinas/sangre , Citocinas/sangre , Diagnóstico Diferencial , Etiopía , Femenino , Infecciones por VIH/sangre , Infecciones por VIH/diagnóstico , Infecciones por VIH/inmunología , Infecciones por VIH/virología , Humanos , Tuberculosis Latente/sangre , Tuberculosis Latente/diagnóstico , Tuberculosis Latente/inmunología , Tuberculosis Latente/microbiología , Masculino , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Proteínas Recombinantes de Fusión/inmunología , Factores de Tiempo , Resultado del Tratamiento , Prueba de Tuberculina , Adulto Joven
11.
Tuberculosis (Edinb) ; 100: 25-31, 2016 09.
Artículo en Inglés | MEDLINE | ID: mdl-27553407

RESUMEN

BACKGROUND: Transcriptomic host biomarkers could assist in developing effective diagnostics, vaccines and therapeutics for tuberculosis (TB). However, different biomarkers may be discriminatory in different populations depending on the host and bacillary genetics and HIV infection, and need to be addressed. METHODS: The expression levels of 45 genes that are known to be involved in or affected by TB pathogenesis were analyzed using dual color Reverse Transcriptase Multiplex Ligation-dependent Probe Amplification (dcRT-MLPA) assay in whole blood of 106 HIV positive individuals including active TB patients (TB(+)HIV(+), n = 29), and non TB patients that are tuberculin skin test positive (TST+) (TST(+)HIV(+), n = 26), or TST negative (TST(-)HIV(+), n = 51). RESULTS: Between the two clinical groups (TB(+)HIV(+) vs. TST(-)HIV(+)) 8 genes were differently expressed (CCL19, CD14, CD8A, FPR1, IL7R, CCL22, TNFRSF1A, and FCGR1A); between TB(+)HIV(+) vs. TST(+)HIV(+), 6 genes (CD14, IL7R, TIMP2, CCL22, TNFRSF1A, and FCGR1A) were differently expressed. Since no difference in gene expression was revealed between TST(+)HIV(+) vs. TST(-)HIV(+), we clustered both the TST(+)HIV(+) and TST(-)HIV(+) individuals as one group (TST(+/-)HIV(+)) and compared gene expression with TB(+)HIV(+) patients. Thus, the results revealed that the levels of five genes (CD8A, TIMP2, CCL22, FCGR1A and TNFRSF1A) were the most accurate single gene markers for differentiation between TB(+)HIV(+) and TST(+/-)HIV(+), with AUCs of 0.71, 0.71, 0.79, 0.83 and 0.73, respectively. However, the combination of two genes (CCL22 + FCGR1A) and FCGR1A alone were the most accurate marker for differentiation between the two groups (TB(+)HIV(+) and TST(+/-)HIV(+)) with AUC of 0.85 and 0.83, respectively. CONCLUSIONS: We showed that five genes (CD8A, TIMP2, CCL22, FCGR1A and TNFRSF1A), specifically FCGR1A and CCL22 have the potential to discriminate active TB from non-active TB in HIV patients in Ethiopia and could be used to improve diagnostic tools for active TB in HIV patients, and to understand the pathogenesis of TB/HIV coinfection.


Asunto(s)
Infecciones Oportunistas Relacionadas con el SIDA/diagnóstico , Infecciones Oportunistas Relacionadas con el SIDA/genética , Tuberculosis/diagnóstico , Tuberculosis/genética , Adolescente , Adulto , Coinfección/diagnóstico , Coinfección/genética , Estudios Transversales , Diagnóstico Diferencial , Femenino , Expresión Génica , Marcadores Genéticos , Humanos , Tuberculosis Latente/diagnóstico , Tuberculosis Latente/genética , Masculino , Persona de Mediana Edad , Prueba de Tuberculina , Adulto Joven
12.
AIDS Res Hum Retroviruses ; 21(7): 649-53, 2005 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16060836

RESUMEN

Most human immunodeficiency virus type 1 (HIV-1) transmission in developing countries occurs through heterosexual intercourse or during birth from mother to child. It is critical to characterize the virus of the genital tract variants as a target for the development of an HIV-1 vaccine and microbicidal therapies. We compared the C2V3 env domain genetic diversity of HIV-1 in female genital secretions and in plasma from Ethiopian women seeking care for sexually transmitted infections (STIs). Sequences within an individual differed between the plasma and cervicovaginal lavage (CLV) compartments with nucleotide and amino acid median difference values of 8.3 and 4.8%, respectively. Sequence diversity in CVL was greater than in plasma. And the V3 loop positive charge was often more elevated in CVL. These are markers of the differential evolution of the viruses in CVL and peripheral blood indicating that limited evolution at the site of contact is not the limiting factor determining the preferential transmission of macrophage tropic viruses.


Asunto(s)
Cuello del Útero/virología , Infecciones por VIH/virología , VIH-1/genética , Enfermedades de Transmisión Sexual/terapia , Vagina/virología , Secuencia de Aminoácidos , Etiopía , Femenino , Proteína gp120 de Envoltorio del VIH/química , Infecciones por VIH/sangre , VIH-1/aislamiento & purificación , Humanos , Datos de Secuencia Molecular , Fragmentos de Péptidos/química , ARN Viral/análisis , Homología de Secuencia de Aminoácido , Enfermedades de Transmisión Sexual/sangre , Enfermedades de Transmisión Sexual/virología , Irrigación Terapéutica
13.
J Health Popul Nutr ; 23(4): 358-68, 2005 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-16599107

RESUMEN

The study was conducted to determine the prevalence, incidence, and risk factors for HIV infection among factory workers at two sites in Ethiopia. During February 1997-December 2001, a structured questionnaire was used for obtaining information on sociodemographics, sexual behaviour, and reported sexually transmitted infections (STIs) from a cohort of 1679 individuals. Serum samples were screened for antibodies against HIV, Treponema pallidum haemaglutination (TPHA), and herpes simplex virus type 2 (HSV-2). The overall baseline prevalence of HIV was 9.4%-8.5% among males and 12.4% among females. For both the sexes, the factors independently associated with an increased risk of HIV infection were widowhood and having had antibodies against TPHA and HSV-2. The risk factors specific for males were being orthodox Christian, having had a higher lifetime number of sexual partners, and genital discharge in the past five years. The risk factors for females, included low income, one or more rape(s) over lifetime, and casual sex in the last year. The overall incidence of HIV infection was 0.4 per 100 person-years. The highest rate of incidence was observed among young women aged less than 30 years (1 per 100 person-years). The study confirmed that high-risk sexual behaviour and STIs play major roles in the spread of HIV infection in the Ethiopians of both the sexes, but the factors, such as rape and low economic status, make women more vulnerable than men.


Asunto(s)
Infecciones por VIH/epidemiología , Industrias , Adulto , Distribución por Edad , Estudios de Cohortes , Etiopía/epidemiología , Femenino , Infecciones por VIH/sangre , Encuestas Epidemiológicas , Herpes Genital/sangre , Herpes Genital/epidemiología , Herpesvirus Humano 2/aislamiento & purificación , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Oportunidad Relativa , Prevalencia , Factores de Riesgo , Distribución por Sexo , Conducta Sexual/estadística & datos numéricos , Enfermedades de Transmisión Sexual/epidemiología , Factores Socioeconómicos , Encuestas y Cuestionarios
14.
Ethiop Med J ; 43(2): 97-101, 2005 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-16370539

RESUMEN

A total of 105 single fresh stool samples were collected from diarrhoeal patients with (80 HIV-positive and 25 HIV-negative) from the Army and the Police hospitals, Addis Ababa. The stool samples were processed by water-ether sedimentation method; they were stained with Uvitex-2B technique for microscopic detection of intestinal microsporidium. A portion of all samples were preserved in 200microl PBS containing 2% PVPP ((Polyvinylpolypyrolidone) for confirmation with PCR. 18/105(17.2%) of the cases were positive for intestinal microsporidial infection by at least one method. 8/105 (7.6%) positive both by microscopy and PCR and 10/105 (9.5%) were positive only by PCR. All microsporidia positive cases were also HIV positive. Based on PCR analysis, 15 Enterocytozoon bieneusi and 3 Encephalitozoon intestinalis were identified. This study has shown that intestinal microsporidiosis is a common cause of chronic diarrhoea in advanced AIDS patients and this is mainly attributed to Enterocytozoon bieneusi. To the best of our knowledge, this is the first report of intestinal microsporidiosis in Ethiopia. It has an important implication for the understanding of the aetiology of diarrhoea in HIV/AIDS patients in the country.


Asunto(s)
Infecciones Oportunistas Relacionadas con el SIDA/microbiología , Diarrea/microbiología , Encephalitozoon/aislamiento & purificación , Enterocytozoon/aislamiento & purificación , VIH-1 , Enfermedades Intestinales/microbiología , Microsporidiosis/diagnóstico , Infecciones Oportunistas Relacionadas con el SIDA/complicaciones , Adolescente , Adulto , Animales , Diarrea/diagnóstico , Etiopía , Femenino , Síndrome de Emaciación por VIH/complicaciones , Síndrome de Emaciación por VIH/microbiología , Humanos , Masculino , Microsporidiosis/complicaciones , Microsporidiosis/microbiología , Reacción en Cadena de la Polimerasa , Coloración y Etiquetado
15.
AIDS ; 18(5): 781-5, 2004 Mar 26.
Artículo en Inglés | MEDLINE | ID: mdl-15075513

RESUMEN

OBJECTIVES: To examine the impact of sexually transmitted diseases (STD) syndromic treatment on genital shedding of HIV and the impact among women in whom STD treatment was not successful. DESIGN: Seventy-one HIV-infected women were included; 60 had symptomatic STD [72% with genital discharge syndrome (GDS) and 28% with genital ulcer syndrome (GUS)] and 11 controls did not have symptomatic STD. Cervical HIV load in 94% women was measured at baseline and after STD treatment. RESULTS: Cervical HIV load at entry was significantly higher in women with symptomatic STD than in controls [median, 3.15; interquartile range (IQR), 1.90-3.34 versus median, 1.90; IQR, 1.90-2.19 log10 RNA copies/swab, respectively; P = 0.024]. Women with STD were also more likely to have detectable cervical HIV RNA (68% versus 27%; P = 0.016). Cervical HIV load was significantly higher in women with GUS than in those with GDS (median 3.46; IQR, 2.84-4.18 versus median, 2.83; IQR, 1.90-3.31 log10 copies/swab; P = 0.019). There was no significant reduction in genital HIV shedding after syndromic treatment of GDS or GUS. However, significant decreases were limited to only those with clinical improvement (median, 2.91; IQR, 1.90-3.45 versus median, 2.25; IQR, 1.90-3.08 log10 RNA copies/swab, respectively; P = 0.006). GUS was significantly associated with treatment failure, independent of plasma HIV RNA load and CD4 T-cell count (odds ratio, 4.79; 95% confidence interval, 1.32-17.46). CONCLUSIONS: The fact that STD syndromic treatment impacts very little in reducing genital HIV shedding underscores the need for appropriate validation of STD syndromic diagnosis and management to control heterosexual transmission of HIV.


Asunto(s)
Países en Desarrollo , Infecciones por VIH/transmisión , VIH-1 , Enfermedades de Transmisión Sexual/tratamiento farmacológico , Adolescente , Adulto , Estudios de Casos y Controles , Cuello del Útero/virología , Distribución de Chi-Cuadrado , Protocolos Clínicos , Femenino , Infecciones por VIH/complicaciones , Infecciones por VIH/virología , VIH-1/genética , Humanos , Persona de Mediana Edad , ARN Viral/análisis , Enfermedades de Transmisión Sexual/complicaciones , Enfermedades de Transmisión Sexual/virología , Carga Viral , Esparcimiento de Virus
16.
Trans R Soc Trop Med Hyg ; 97(3): 305-7, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-15228248

RESUMEN

To confirm the high reported incidence of intestinal amoebiasis among study participants at 2 cohort sites in Ethiopia where an HIV/AIDS study is taking place, stool samples of 232 patients with complaints of diarrhoea were examined for the presence of Entamoeba histolytica and E. dispar DNA between April and December 2001. By microscopy, 91 (39%) of the study participants were reported to harbour Entamoeba trophozoites and/or four-nucleated cysts. Using specific E. histolytica and E. dispar DNA amplification and detection, none of the study participants were found to be infected with E. histolytica and only 21 (9%) with E. dispar. The consequences of the overdiagnosis of E. histolytica are briefly discussed.


Asunto(s)
Diarrea/parasitología , Disentería Amebiana/diagnóstico , Entamoeba histolytica/aislamiento & purificación , Adolescente , Adulto , Anciano , Animales , Niño , Preescolar , ADN Protozoario/análisis , Disentería Amebiana/epidemiología , Disentería Amebiana/parasitología , Etiopía/epidemiología , Heces/parasitología , Femenino , Humanos , Lactante , Masculino , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa/métodos , Estudios Prospectivos
17.
Ethiop Med J ; 41(2): 189-203, 2003 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15227978

RESUMEN

Infectious diseases are a significant cause of morbidity and mortality among HIV-infected persons in Ethiopia. Though no systematic studies have been performed, anecdotal reports are available mostly from cross-sectional studies on the associations between the most prevalent infectious diseases and HIV/AIDS. In this review, we present the most frequently reported infectious diseases among people living with HIV/AIDS in the country, with the need for strengthening diagnostic laboratories being urgent in order to support surveillance as well as control measures.


Asunto(s)
Infecciones Oportunistas Relacionadas con el SIDA/epidemiología , Infecciones Oportunistas Relacionadas con el SIDA/clasificación , Etiopía/epidemiología , Heterosexualidad , Humanos , Infecciones por Mycobacterium/epidemiología , Infecciones por Mycobacterium/etiología , Micosis/epidemiología , Micosis/etiología , Enfermedades Parasitarias/epidemiología , Enfermedades Parasitarias/etiología , Prevalencia , Enfermedades de Transmisión Sexual/epidemiología , Enfermedades de Transmisión Sexual/etiología , Virosis/epidemiología , Virosis/etiología
18.
Ethiop Med J ; 40 Suppl 1: 11-6, 2002 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-12802827

RESUMEN

The CD4+ T-lymphocyte count is a widely used marker of HIV disease progression. The marker also plays a crucial role in determining therapeutic interventions in HIV infections, especially with the initiation and monitoring of antiretroviral therapy and prophylactic treatment for opportunistic infections. In general, immunological studies done thus far on adult Ethiopians revealed that, healthy HIV-negative Ethiopians exhibit significantly decreased values for absolute CD4 counts than other populations. However, it remains to be illucidated whether Ethiopian AIDS patients develop opportunistic infections at much lower CD4 values than AIDS patients from Western countries, and whether Ethiopian HIV infected patients progress to AIDS more rapidly. Thus, establishing locally appropriate standard CD4 values is important in order to implement certain prophylactic or therapeutic interventions in our setting. Most of these studies are reported on international journals, which are hardly accessible to the Ethiopian medical/scientific community. The aim of this mini-review is, therefore, to provide the local scientific community and clinicians with the available information.


Asunto(s)
Recuento de Linfocito CD4/estadística & datos numéricos , Seronegatividad para VIH , Linfopenia/sangre , Sesgo , Camerún , Progresión de la Enfermedad , Monitoreo de Drogas/métodos , Monitoreo de Drogas/normas , Etiopía/epidemiología , Infecciones por VIH/sangre , Infecciones por VIH/tratamiento farmacológico , Seronegatividad para VIH/inmunología , Humanos , Kenia , Linfopenia/epidemiología , Valores de Referencia , Tanzanía , Uganda
19.
Ethiop Med J ; 42(1): 41-7, 2004 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-15884276

RESUMEN

A retrospective study was conducted to examine trends in HIV-1 prevalence among visa applicants between the years 1993 to 2001 in Urban Ethiopia. A total of 63,869 visa applicants were screened during these nine years period. The majority of them (79.5%) were females. Their mean age was 31.6 and 25.7 years for males and females, respectively. HIV-1 prevalence ranged from 6.8% in 1993 to 10.4% in 1997 (test for trend: p<0.001), while it seems stabilized at around 11% after 1997. The overall period prevalence was 9.5%. The peak prevalence was documented in the age group 25-29 for females (12.1%) while it was in the age group 30-34 for males (11.4%). This study, therefore, confirms the severity of the HIV-1 epidemic in the country. Visa applicants can be used as a sentinel population for monitoring trends in HIV-1 prevalence in the country, although additional socio-demographic information would be useful for better interpretation of such data.


Asunto(s)
Anticuerpos Anti-VIH/sangre , Infecciones por VIH/diagnóstico , Infecciones por VIH/epidemiología , Seroprevalencia de VIH/tendencias , VIH-1/inmunología , Internacionalidad , Viaje , Salud Urbana/estadística & datos numéricos , Adolescente , Adulto , Distribución por Edad , Ensayo de Inmunoadsorción Enzimática , Etiopía/epidemiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Factores de Riesgo , Vigilancia de Guardia , Distribución por Sexo , Factores de Tiempo , Salud Urbana/tendencias
20.
Ethiop Med J ; 40 Suppl 1: 27-36, 2002 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-12802829

RESUMEN

To evaluate a simple and rapid testing strategy to diagnose HIV infection in Ethiopia, we subjected a panel of 688 sera with known HIV serologic status (confirmed by ELISA/WB or double ELISA) to 3 rapid assays: Determine HIV-1/2, Capillus HIV-1/2 and Serocard HIV. Samples were obtained from participants in a cohort study on HIV-infection (72%), from tuberculosis patients (18%) and from participants in surveillance studies among police recruits and commercial sex workers (10%). The panel consisted of 249 HIV-1 positive samples, of which 68 were HIV-1 subtype C and 1 HIV-1 subtype A, and 439 HIV-1 negative samples. Determine and Capillus were 100% sensitive and 99.8% specific, Serocard was 100% sensitive and specific. On retrospective evaluation, both parallel (samples tested simultaneously by two rapid assays) and serial (samples tested by two consecutive rapid assays) testing algorithms were 100% sensitive and specific when compared to ELISA/WB or double ELISA testing strategy. In conclusion rapid assays have high sensitivity and specificity. HIV serodiagnosis based on rapid assays may therefore be a valuable alternative in voluntary counselling and testing centres and in facilities where sophisticated laboratories are not available.


Asunto(s)
Serodiagnóstico del SIDA/métodos , Ensayo de Inmunoadsorción Enzimática/métodos , Infecciones por VIH/diagnóstico , VIH-1 , Tamizaje Masivo/métodos , Serodiagnóstico del SIDA/normas , Algoritmos , Western Blotting , Ensayo de Inmunoadsorción Enzimática/normas , Etiopía , Infecciones por VIH/sangre , Infecciones por VIH/inmunología , VIH-1/inmunología , Humanos , Tamizaje Masivo/normas , Policia , Estudios Retrospectivos , Sensibilidad y Especificidad , Trabajo Sexual , Factores de Tiempo , Tuberculosis/sangre , Tuberculosis/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA